FGF19 and hepatocellular carcinoma: However, numerous pieces of evidence indicated that FGF15/19 is not physiologically expressed in the liver, but pathological FGF19 expression was detected in liver tissues of patients with liver diseases, including hepatitis C virus cirrhosis, cholestasis, and HCC (Inagaki et al., 2007; Naugler et al., 2015).